Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13401
CALL
Neonode
NEON
$13.8M
| $13.8K | ﹤0.01% |
14,700
-18,500
| -56% | -$27.5K |
|
13402
PUT
Kartoon Studios
TOON
$34.8M
| $13.6K | ﹤0.01% |
+19,200
| New | +$13.7K |
|
|
FTRK
13403
DELISTED
Fast Track Group
FTRK
| $13.5K | ﹤0.01% |
+30,418
| New | +$12.9K |
|
|
ITOC
13404
iTonic Holdings
ITOC
$5.06M
| $13.1K | ﹤0.01% |
43,379
+13,826
| +47% | +$4.49K |
|
|
AIDX
13405
20/20 Biolabs Inc
AIDX
$6.08M
| $12.8K | ﹤0.01% |
23,205
+6,978
| +43% | +$8.76K |
|
|
STKE
13406
CALL
Sol Strategies Inc
STKE
$44.5M
| $12.8K | ﹤0.01% |
10,900
-157,100
| -94% | -$213K |
|
13407
Abits Group
ABTS
$4.6M
| $12.7K | ﹤0.01% |
+10,980
| New | +$13.7K |
|
|
WHLR
13408
Wheeler Real Estate Investment Trust
WHLR
$1.31M
| $12.6K | ﹤0.01% |
+505
| New | +$57.1K |
|
13409
La Rosa Holding
LRHC
$8.83M
| $12.6K | ﹤0.01% |
+1,805
| New | +$22.7K |
|
|
KNRX
13410
Knorex Ltd
KNRX
$9.89M
| $12.4K | ﹤0.01% |
+25,637
| New | +$23.8K |
|
13411
CALL
Destination XL Group
DXLG
$35.3M
| $12.3K | ﹤0.01% |
18,300
-327,900
| -95% | -$216K |
|
13412
PUT
Gossamer Bio
GOSS
$63.4M
| $12.2K | ﹤0.01% |
925
-1,215
| -57% | -$27.1K |
|
13413
authID Inc
AUID
$7.86M
| $12.1K | ﹤0.01% |
+11,334
| New | +$13.3K |
|
13414
PUT
Standard BioTools
LAB
$271M
| $12.1K | ﹤0.01% |
14,700
-6,500
| -31% | -$6.14K |
|
13415
CALL
Brilliant Earth
BRLT
$23.5M
| $12.1K | ﹤0.01% |
+10,700
| New | +$13.6K |
|
13416
CALL
Rani Therapeutics
RANI
$94.8M
| $12K | ﹤0.01% |
15,800
-260,800
| -94% | -$231K |
|
|
VSTD
13417
DELISTED
Vestand Inc
VSTD
| $12K | ﹤0.01% |
+55,947
| New | +$19.9K |
|
|
BBBYW
13418
Neighborhood Intelligence Inc Warrants
BBBYW
$4.53M
| $12K | ﹤0.01% |
28,501
+1,314
| +5% | +$719 |
|
|
FMFC
13419
Kandal M Venture Ltd
FMFC
$3.59M
| $11.3K | ﹤0.01% |
+39,567
| New | +$14.9K |
|
|
13420
CALL
Standard BioTools
LAB
$271M
| $11.3K | ﹤0.01% |
13,700
-8,300
| -38% | -$7.84K |
|
|
MDCX
13421
Medicus Pharma
MDCX
$9.61M
| $11.2K | ﹤0.01% |
25,102
+7,278
| +41% | +$2.58K |
|
13422
CALL
Heron Therapeutics
HRTX
$59.6M
| $11.1K | ﹤0.01% |
26,100
-8,500
| -25% | -$6.82K |
|
|
BRNX
13423
BrenX
BRNX
$4.68M
| $11K | ﹤0.01% |
+2,257
| New | +$28.8K |
|
13424
CALL
Retractable Technologies
RVP
$20.4M
| $10.9K | ﹤0.01% |
15,100
+1,200
| +9% | +$816 |
|
13425
Integrated Media Technology
IMTE
$1.78M
| $10.9K | ﹤0.01% |
23,029
-57,857
| -72% | -$31.8K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.